Journal profile

Canadian journal of psychiatry. Revue canadienne de psychiatrie

Publisher: Sage
ISSN0706-7437 | 1497-0015 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.71
Citation rate 4.49 584 total citations
h5-index 33 h5 depth signal
Cited share 77.1% 111 of 144
Total citations 584 Citation footprint
Metric signal 4.70 External metric anchor
Self-citation 5.7% 33 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

Canada 961
United States 195
United Kingdom 81
Australia 63
France 31

Citing Fields of Research

Psychiatry 821
Psychiatry & Psychology 332
Substance Abuse 163
Healthcare Policy 87
Neurosciences 62

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 8,818 Articles tracked across the journal lifetime
Indexed publication set 144 111 cited publications
Last 12 months 122 10.2 publications/month
Open access share 59.8% 73 OA publications in the last year
Leading citing country Canada 961 citing publications
Leading citing field Psychiatry 821 citing publications
Latest tracked publication 14 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v24n1, 1979-
PubMed
v24n1, 1979-
Index medicus
Active Coverage
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Psychiatry

Issuing & Sponsoring Bodies

Contributor
Canadian Psychiatric Association

Broad Categories

Psychiatry Psychiatry Substance Abuse Psychiatry & Psychology

MeSH Descriptors

Psychiatry

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Alexandre Hudon, Fanie Chainey, Catherine Degré et al.
Objective: To evaluate the longitudinal stability of DUNDRUM-1 Triage Security Scale recommendations among individuals found not criminally responsible on account of mental disorder (NCRMD) receiving care within a Canadian forensic psych...
03
Jonathan C. W. Liu, Ilona Gorbovskaya, Amy Y. Zhang et al.
Background: Schizophrenia (SCZ) is a debilitating disorder affecting approximately 1% of the Canadian population and remains a major contributor to disease burden and disability. Up to one-third of individuals with SCZ are affected by tr...
04
Reza Rafizadeh, Laura Frankow, Vijaykumar Seethapathy et al.
Background: Individuals with schizophrenia and concurrent substance use disorders (SUDs) face a high risk of rapid weight gain during residential treatment, driven by inpatient environmental factors, baseline metabolic vulnerability, and...
06
Myanca Rodrigues, Brittany B. Dennis, Behnam Sadeghirad et al.
Objective: To assess the comparative benefits and harms of opioid substitution and antagonist therapies (OSATs) for opioid use disorder (OUD) using a network meta-analysis (NMA) of randomized controlled trials (RCTs). Data Sources: Medli...
07
Lu Yang, Kate Ross, Mackenzie Palmer et al.
Objective: To examine adherence to smartphone- and wearable-based digital phenotyping in patients with first-episode psychosis (FEP) and explore stakeholder perspectives on its potential application for outcome prediction. Method: We con...
08
James Mirabelli, James MacKillop, David Streiner et al.
Background: Individuals with borderline personality disorder (BPD) frequently use cannabis, often for self-medication. However, cannabis use has also been linked to BPD symptom severity, suggesting heterogeneity in its effects. Individua...
10
Rafal M. Skiba, Todd S. Woodward, Ivan Caramanna et al.
Objective: Language and communication disturbances are enduring features of schizophrenia, often manifesting as impoverishment of speech. This exploratory study aims to examine how communicative deficits overlap with a cognitive profile ...

Bibliographical & Catalog Notes

Supplements accompany some vols.

Also issued online.

Articles in English or French; summaries in both languages.

Official journal of the Canadian Psychiatric Association.